Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | 3M Co | 68 |
| 2 | Pfizer Inc | 18 |
| 3 | Grünenthal Pharma GmbH and Co KG | 13 |
| 4 | Siemens AG | 10 |
| 5 | The University of Texas System | 10 |
| 6 | Columbia University | 9 |
| 7 | Astellas Pharma Inc | 8 |
| 8 | Council of Scientific and Industrial Research | 7 |
| 9 | Henkel AG and Co KGaA | 7 |
| 10 | Solventum Corp | 7 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 276 |
| 2 | A61P | Therapeutic activity (drug indications) | 236 |
| 3 | C12N | Microorganisms, enzymes | 162 |
| 4 | Y02A | Climate change adaptation | 130 |
| 5 | C07K | Peptides | 111 |
| 6 | G01N | Investigating / analysing materials | 108 |
| 7 | A01N | Preservation of bodies; biocides; pest repellents | 102 |
| 8 | C12Q | Measuring/testing involving enzymes | 73 |
| 9 | C12R | 56 | |
| 10 | C07D | Heterocyclic compounds | 53 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Proteins specific for pyoverdine and pyochelin | 2018 | Palvella Therapeutics Inc | 1 |
| A novel protein specific for pyoverdine and pyokerin | 2021 | 0 | |
| Fusion molecules with binding specificity for pyoverdin type I, II and III and pyoquelin | 2018 | 0 | |
| Novel proteins specific for pyoverdine and pyochelin | 2017 | Palvella Therapeutics Inc | 0 |
| Specific proteins for pyoverdin and pyoquelin | 2017 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 19 |
| 2017 | 24 |
| 2018 | 25 |
| 2019 | 17 |
| 2020 | 18 |
| 2021 | 7 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 16 |
| 2025 | 4 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | H. Budzikiewicz | University of Cologne | 40 |
| 2 | Pierre Cornélis | Vrije Universiteit Brussel | 28 |
| 3 | Iain L. Lamont | University of Otago | 27 |
| 4 | Isabelle J. Schalk | Centre National de la Recherche Scientifique | 27 |
| 5 | Jean‐Marie Meyer | Centre National de la Recherche Scientifique | 18 |
| 6 | Mohamed Abou‐Elwafa Abdallah | Centre National de la Recherche Scientifique | 13 |
| 7 | F. Pattus | Centre National de la Recherche Scientifique | 12 |
| 8 | Francesco Imperi | Sapienza University of Rome | 11 |
| 9 | Paolo Visca | Roma Tre University | 10 |
| 10 | Ashleigh S. Griffin | University of Oxford | 9 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Iron and Pseudomonas aeruginosa biofilm formation | 2005 | 803 | Bacterial Genetics and Biotechnology |
| Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa | 2002 | 585 | Bacterial Genetics and Biotechnology |
| Pyoverdin is essential for virulence of Pseudomonas aeruginosa | 1996 | 529 | Bacterial Genetics and Biotechnology |
| Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species | 2000 | 442 | Bacterial Genetics and Biotechnology |
| Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles | 2014 | 422 | Bacterial Genetics and Biotechnology |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Pyoverdin?
Which organizations have filed the most patents related to Pyoverdin?
What are the primary research areas for Pyoverdin patents and publications?
Who are the most prolific authors publishing on Pyoverdin?
How has research activity on Pyoverdin changed in recent years?